Elyce Cardonick, MD, Dzhamala Gilmandyar, MD, and Robert A. Somer, MD OBJECTIVE: To estimate the effect of dose-dense chemotherapy during pregnancy on maternal and neonatal outcomes. METHODS: This is a retrospective cohort study in which women were identified from the international Cancer and Pregnancy Registry at Cooper Medical School at Rowan University in Camden, New […]
Maternal and Fetal Outcomes Elyce Cardonick, MD,* Rebecca Dougherty, MD,† Generosa Grana, MD,‡ Dzhamlaa Gilmandyar, MD,§ Sadia Ghaffar, MD,¶ and Aniqa Usmani, MD Cancer can complicate pregnancy, occurring in 1 per 1000 pregnancies, with 3500 cases estimated annually. Breast cancer is the most common malignancy occurring during pregnancy. Because more women delay childbearing to later […]
Elyce Cardonick, Farhana Irfan, Natalie Torres ABSTRACT Introduction: Little is known about the effects stem cell mobilizers (GCSF) such as neulasta (pegfilgrastim) or neupogen (filgrastim) during pregnancy, and these are often withheld from women undergoing chemotherapy during pregnancy. Materials and Methods: Women receiving chemotherapy during pregnancy were identified from the Cancer and Pregnancy Registry maintained […]
Patty Sosnader, pregnant with her third child, was frighteningly ill. The 33-year-old Norriton sales executive had been battling exhaustion, night sweats, shortness of breath, and a cough that awakened her and her husband, Glen, night after night. At first she assumed it was just pregnancy fatigue. Then she figured it was a cold. Then her […]
Researching pregnant women with cancer and their children. By pooling information into a central registry we can accumulate stronger data to help oncologists, obstetricians and patients make informed decisions about treating cancer in pregnancy.
The Cancer and Pregnancy Fund of the Cooper Foundation is a 501(c)(3) nonprofit organization.